Evelo Biosciences, Inc. Made Big Gain
Tue, Jul 18, 2023 at 07:33 PM
Evelo Biosciences, Inc. (EVLO:NASDAQ) jumped higher at $5.74, a gain of 61.7%. On Tue, Jul 18, 2023, EVLO:NASDAQ hit a New 2-Week High of $5.74. The stock appeared on our News Catalysts scanner on Tue, Jul 18, 2023 at 10:54 AM in the 'BIOTECH' category. From Wed, Jul 05, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Thu, Apr 27, 2023 at $6.4 with a volume of 9M+.
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 1400%
- iCAD, Inc. (ICAD:NASDAQ), 74.27%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 61.69%
- Biophytis SA (BPTS:NASDAQ), 44.65%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 38.8%
- Hempacco Co. Inc. (HPCO:NASDAQ), 36.67%
- Hyperfine Inc. (HYPR:NASDAQ), 35.47%
- ViewRay, Inc. (VRAY:NASDAQ), 29.05%
- Advanced Emissions Solutions, Inc. (ADES:NASDAQ), 28.93%
- The Singing Machine Company Inc. (MICS:NASDAQ), 26.58%